comparemela.com

Latest Breaking News On - Imugene limited - Page 10 : comparemela.com

Here are the top 10 ASX 200 shares today

The S&P/ASX 200 Index (ASX: XJO) put on a rocky performance on Wednesday, closing the session 0.02% higher at 7,237.2 points.

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Guess which ASX 200 healthcare share is surging 5% on a new US patent?

The share price of ASX 200 biopharmaceutical developer Imugene Limited (ASX: IMU) is soaring after the company announced a new US patent.

Here are the top 10 ASX 200 shares today

The S&P/ASX 200 Index (ASX: XJO) ended the week in the red. The index closed Friday’s session 0.76% lower at 7,433.7 points.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.